Prognostic value of microalbuminuria on admission in patients with acute pulmonary embolism

Acute pulmonary embolism (APE) is not only associated with a high rate of morbidity and mortalitya but also associated with increased costs worldwide.1 Thus, early prediction of adverse events have been increasingly important to guide the management of patients with APE.2,3 Previous studies have reported that older age,  hemodynamic instability, high levels of natriuretic peptides and troponins, and higher burden of comorbidities are associated with a poor prognosis in APE.4–6 Several tools such as pulmonary embolism severity index (PESI) have also been developed for assessing the severity of the disease.

Source: Heart and Lung - November 1, 2020 Category: Intensive Care Authors: Ömer Doğan Alataş, Murat Biteker Source Type: research